26 May 2013
Keywords: fda, approves, abbott, cholesterol, drug, health, care
Article | 22 December 2008
US health care major Abbott Laboratories has received Food and Drug Administration approval for its TriLipix (fenofibric acid)
delayed-release capsules ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2008
8 December 2008
24 May 2013
© 2013 thepharmaletter.com